A study finds some evidence that a cancer drug, nilotinib, may help people with Parkinson’s disease, a nervous system disorder that causes movement problems. It possibly works by raising levels of dopamine, the brain chemical that is lacking in people with the disease.

A study finds some evidence that a cancer drug, nilotinib, may help people with Parkinson’s disease, a nervous system disorder that causes movement problems. It possibly works by raising levels of dopamine, the brain chemical that is lacking in people with the disease.